{'fraction_non_alphanumeric': 0.03991811668372569, 'fraction_numerical': 0.04605936540429888, 'mean_word_length': 4.963414634146342, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils.

In this study evidence for the presence of specific cytosolic platelet-activating factor (PAF) binding sites has been presented. The equilibrium dissociation constant (Kd) as determined by Scatchard analysis was 4.29 x 10(-9) M for the cytosolic and 3.71 x 10(-9) M for the membrane fraction. The maximal number of binding sites estimated were 219 fmol/100 micrograms protein for the cytosol and 154 fmol/100 micrograms protein for the membrane, respectively. The specific receptor binding of [3H]PAF to cytosol could be displaced by two potent specific PAF receptor antagonists, BN 50739 and WEB 2086, the equilibration inhibition constants (Ki) being 1.27 x 10(-7) M and 5.7 x 10(-6) M, respectively. These data demonstrate clearly the role of intracellularly synthesized PAF as a second messenger in the receptor-mediated neutrophil activation.